Glucotrack, Inc. (GCTK) stock
GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)
Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –
Glucotrack operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Glucotrack's operating cash flow for the twelve months ending Jun 30, 2026 was -$16.22M. For fiscal 2025 it was -$15.24M. The highest annual figure on record is -$1.16M in fiscal 2009.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.24M | – |
| FY2024 | Dec 31, 2024 | -$12.49M | – |
| FY2023 | Dec 31, 2023 | -$6.56M | – |
| FY2022 | Dec 31, 2022 | -$3.73M | – |
| FY2021 | Dec 31, 2021 | -$3.77M | – |
| FY2020 | Dec 31, 2020 | -$3.50M | – |
| FY2019 | Dec 31, 2019 | -$3.90M | – |
| FY2018 | Dec 31, 2018 | -$4.89M | – |
| FY2017 | Dec 31, 2017 | -$5.90M | – |
| FY2016 | Dec 31, 2016 | -$5.31M | – |
| FY2015 | Dec 31, 2015 | -$4.57M | – |
| FY2014 | Dec 31, 2014 | -$3.36M | – |
| FY2013 | Dec 31, 2013 | -$3.22M | – |
| FY2012 | Dec 31, 2012 | -$2.30M | – |
| FY2011 | Dec 31, 2011 | -$1.92M | – |
| FY2010 | Dec 31, 2010 | -$1.37M | – |
| FY2009 | Dec 31, 2009 | -$1.16M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.62M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.05M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.94M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.62M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.74M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.94M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.50M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.14M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.91M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.94M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.41M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.88M | – |
| Q2 FY2023 | Jun 30, 2023 | -$954.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.31M | – |
| Q4 FY2022 | Dec 31, 2022 | -$940.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$608.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$916.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.27M | – |
| Q4 FY2021 | Dec 31, 2021 | -$973.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$894.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$969.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$933.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$844.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$765.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$903.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$989.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$796.49K | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.06M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.22M | – |
| Q1 FY2019 | Mar 31, 2019 | -$821.02K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.09M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.36M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.02M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.43M | – |
| Q4 FY2017 | Dec 31, 2017 | -$788.01K | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.50M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.46M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.15M | – |
| Q4 FY2016 | Dec 31, 2016 | -$965.54K | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.46M | – |
See a number that looks wrong?